The S&P 500 ended Tuesday's choppy session slightly lower as investors waited for clarity on U.S. trade policy after ...

Moderna has a P/B ratio of 1.25. This indicates that the market value of the company exceeds its book value by a factor of ...

The S&P 500 fell 0.1% on Tuesday, July 8, 2025, after President Trump extended the deadline for "reciprocal" tariffs and ...

Moderna shares surged 9.5% amid legal backlash against vaccine policy changes. Will it be a turning point for MRNA which is struggling with weaker sales?

The S&P 500’s biggest gainer was Moderna Inc (BMV: MRNA) up more than 9% after leading medical organizations filed a lawsuit ...

Major health groups sue HHS and Robert F. Kennedy Jr. over COVID-19 vaccine policy changes for children and pregnant ...

Moderna (MRNA), an undervalued name in the biotech space, rose to prominence during the COVID-19 pandemic. This occurred when ...

Mizuho analyst Vijay Rakesh maintained Microchip Technology with an Outperform rating and raised the price target from $78 to ...

View the latest Moderna Inc. (MRNA) stock price, news, historical charts, analyst ratings and financial information from WSJ.

According to the CDC, there has been a decline in animal infections and no reports of human cases since February.

The U.S. Centers for Disease Control and Prevention ended its emergency response for bird flu as the outbreak that sickened ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.